| Bioactivity | PCSK9-IN-31 (Compound WX002) is an orally active PCSK9 inhibitor. PCSK9-IN-31 can lower low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in high cholesterol fed model rats[1]. |
| CAS | 2247649-76-7 |
| Formula | C23H26N4O3 |
| Molar Mass | 406.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wenjie Xu, et al. CRYSTAL FORM α OF COMPOUND A, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING CRYSTAL FORM. Patent. WO2020078170A1. |
PCSK9-IN-31
CAS: 2247649-76-7 F: C23H26N4O3 W: 406.48
PCSK9-IN-31 (Compound WX002) is an orally active PCSK9 inhibitor. PCSK9-IN-31 can lower low-density lipoprotein choleste
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.